Okay, let's tackle this question. The user is asking which drug is used as a transcranial patch for Parkinson's disease. First, I need to recall the drugs available for Parkinson's. Common ones include levodopa, dopamine agonists like pramipexole, MAO-B inhibitors, COMT inhibitors, and maybe some newer delivery methods.

Transcranial patch sounds like a method of administration, so maybe a patch that delivers the drug through the skin to the brain. Wait, transcranial could mean across the skull, but more likely it's a typo for transdermal. Transdermal patches are common for drugs like scopolamine or nicotine. But for Parkinson's, there's a transdermal patch for rotigotine. Rotigotine is a dopamine agonist, right? It's delivered via a patch, which is applied to the skin. So the correct answer is Rotigotine.

Now, the options are A, B, C, D but without the specific names, I need to think of the distractors. Common Parkinson's drugs that aren't used as patches would include levodopa, which is usually in combination with carbidopa. Dopamine agonists like pramipexole are oral. MAO-B inhibitors like selegiline or rasagiline are oral too. COMT inhibitors like entacapone. So the wrong options would be these drugs. The transdermal patch for rotigotine is a key point here.

Clinical pearl: Remember that rotigotine is the dopamine agonist available as a transdermal patch. This is a high-yield fact for exams. So the correct answer is Rotigotine. The other options don't come as transdermal patches. Need to make sure the explanation is clear and covers why the others are wrong.

**Core Concept**
The question tests knowledge of drug delivery methods for Parkinson’s disease, specifically transdermal administration. Rotigotine, a dopamine agonist, is uniquely available as a transdermal patch to bypass first-pass metabolism and provide continuous dopaminergic stimulation.

**Why the Correct Answer is Right**
Rotigotine is a non-ergot dopamine agonist delivered via a transdermal patch (e.g., Neupro). The patch adheres to the skin, allowing controlled absorption through the dermis into systemic circulation. This method ensures steady drug levels, reducing motor fluctuations and dyskinesias associated with oral formulations. The transdermal route avoids gastrointestinal variability and hepatic metabolism, enhancing therapeutic efficacy.

**Why Each Wrong Option is Incorrect**
**Option A:** Levodopa is the cornerstone of Parkinson’s treatment but is administered orally, often combined with carbidopa to prevent peripheral decarboxylation.
**Option B:** Pramipexole, another dopamine agonist, is available as an oral tablet, not a transdermal patch.
**Option C:** Selegiline (an MAO-B inhibitor) is an oral medication, typically in immediate-release or extended-release formulations.
**Option D:** Entacapone (a COMT inhibitor) is an oral adjunct to levodopa, enhancing its duration of action.

**Clinical Pearl / High-Yield Fact**
**Rotigotine patch** is the only Parkinson’s drug administered transdermally. Remember: “Patch = Rotigotine” for exams. Avoid confusing it with other dopamine

✓ Correct Answer: B. Rotigotine